Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 5:29 PM ET

Pharmaceuticals

Company Overview of Warner Chilcott plc

Executive Profile

John A. King Ph.D.

Former Director and Member of Quality & Operations Committee, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
65$276,420

Background

Dr. John A. King, Ph.D., served as the Chief Executive Officer of Galen Pharmaceutical. Dr. King joined Galen Pharmaceutical in 1979. Dr. King served as Managing Director of Warner Chilcott PLC since 1984 and served as its Chief Executive since 1991. Previously, he served as Technical Director of Warner Chilcott PLC since 1981. He joined Warner Chilcott in 1979 as the Technical Manager and was responsible for the development and registration of new products. He led the ...

Corporate Headquarters

1 Grand Canal Square
Dublin, Co. Dublin 2

Ireland

Phone: 353 1 897 2000
Fax: --

Board Members Memberships

Director
Director
Director
2005-N/A
Non-Executive Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2005-N/A
Former Director
2013-2015
Former Director and Member of Quality & Operations Committee

Education

PhD 1974
Queen’s University of Belfast
ScD
Queen’s University of Belfast
BS
Queen’s University of Belfast

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$151,375
Total Calculated Compensation$276,420
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$2.0M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
$15.2M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Warner Chilcott plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.